Skip to content

Clinical trials

Completed Testicular Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Testicular Neoplasms Status: Completed Clear all

175 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20008
20015
20028
200312
200412
20058
20067
20079
20084
20094
20102
20116
20124
20134
20142
20157
20165
20173
20184
20193
20203
20216
20222
20232
20242
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed175

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)15
Memorial Sloan Kettering Cancer Center14
Fred Hutchinson Cancer Center13
Children's Oncology Group11
National Institutes of Health Clinical Center (CC)5
University Medical Center Groningen5
European Organisation for Research and Treatment of Cancer - EORTC4
Medical Research Council4
Eastern Cooperative Oncology Group3
Wake Forest University Health Sciences3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Testicular Neoplasms175
Breast Neoplasms58
Ovarian Neoplasms48
Neuroblastoma46
Burkitt Lymphoma45
Lymphoma, Non-Hodgkin45
Precursor Cell Lymphoblastic Leukemia-Lymphoma45
Teratoma44
Carcinoma, Ovarian Epithelial43
Hodgkin Disease42

Trials

Showing 76 to 100 of 175. Each trial links to its page on Pharma Observatory.

75 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.